Regional segmentation of the Aspergillosis Treatment Market covers North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. Because of increased government initiatives for infection diagnosis and treatment, the North American Aspergillosis treatment market is likely to dominate. The Infectious Diseases Society of America (IDSA) published revised guidelines for the diagnosis and treatment of Aspergillus species infections in 2016. The publication provides guidelines on non-culture-based Aspergillus infection detection and discourages the use of combination anti-fungal medication for primary management.
The guidelines also specify the treatment of isavuconazole, a new anti-fungal medicine approved by the FDA in March 2015 to treat mucormycosis and aspergillosis.
Read More:
https://knackersblogger.blogspot.com/2022/10/aspergillosis-treatment-market-global.html
